Fulltext

Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells

Wathikthinnakon M 1 , Luangwattananun P 2 , Sawasdee N 2 , Chiawpanit C 1 , Lee VS 3 , Nimmanpipug P 4 Show all authors , Tragoolpua Y 5 , Rotarayanont S 5 , Sangsuwannukul T 2 , Phanthaphol N 2 , Wutti-In Y 2 , Somboonpatarakun C 2 , Chieochansin T 2 , Junking M 2 , Sujjitjoon J 2 , Yenchitsomanus PT 6 , Panya A 7

Affiliations 

  • 1 Doctoral Program in Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand
  • 2 Division of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok, 10700, Thailand
  • 3 Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
  • 4 Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand
  • 5 Department of Biology, Faculty of Science, Chiang Mai University, 293, Hauy Kaew Road, Muang District, Chiang Mai, 50200, Thailand
  • 6 Division of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok, 10700, Thailand. ptyench@gmail.com
  • 7 Department of Biology, Faculty of Science, Chiang Mai University, 293, Hauy Kaew Road, Muang District, Chiang Mai, 50200, Thailand. aussara.pan@cmu.ac.th
Sci Rep, 2025 Feb 06;15(1):4515.
PMID: 39915564 DOI: 10.1038/s41598-025-88644-7

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications